Assyro AI

Orange Book product · Brand (NDA)

RUKOBIA

FOSTEMSAVIR TROMETHAMINE

Brand (NDA)NDA 212950RX VIIV HLTHCARE

At a glance

Jul 02, 2020

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 02, 2020

    6 yr 1 mo ago

  2. Today

  3. Patent 7745625 expires

    Listed drug substance patent expiration.

    Nov 19, 2027

    in 1 yr 5 mo

  4. Patent 8168615 expires

    Listed drug product patent expiration.

    Jul 13, 2029

    in 3 yr 1 mo

Pharmaceutical detail

Active ingredient

FOSTEMSAVIR TROMETHAMINE

Strength

EQ 600MG BASE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

TE code

Not listed

Application

NDA 212950

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7745625Nov 19, 2027in 1 yr 5 mo
Substance
8168615Jul 13, 2029in 3 yr 1 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.